Clinical Trial

Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer

Study acronym: RECTIL
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy of erectile rehabilitation with Sildenafil, in men treated with neoadjuvant proctectomy and radiotherapy for rectal cancer, in preventing long-term erectile dysfunction at 12 months post-operatively.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-05-13
notable Trial sites expanded: 0 -> 14 locations 2026-05-13
Trial Details
NCT Number NCT06123156
Lead Sponsor University Hospital, Rouen
Conditions Rectal Cancer
Enrollment 188 participants
Start Date 2025-09-25
Primary Completion 2030-02 (estimated)
Study Completion 2030-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-12